← All trials
NCT02145715
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2013
- Primary completion
- Jul 1, 2015
- Completion date
- Jan 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 54
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- University of LeedsLead sponsor
- University of LeedsSponsor investigator
- NovartisCollaborator
- Myeloma UKCollaborator
- Barts & The London NHS TrustOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.